A 37-year-old man who had sex with men presented with a 5-day history of bloody diarrhea, abdominal pain, and fever. Four weeks prior to the current presentation, he had sought medical attention because of weight loss of 15 kg over 3 months and was diagnosed with HIV infection. Ten days earlier, he had started antiretoroviral therapy (ART), which included elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate, with a CD4 cell count of 60/mL. Diffuse abdominal tenderness was noted. An enhanced abdominal computed tomography showed marked colon wall thickening ( Fig. 1, arrows) . Colonoscopy revealed mucosal edema and ulcerations throughout the colon (Fig. 2) . Biopsy specimens from the colon showed mucosal inflammation, intranuclear inclusions (Fig. 3, arrows) , and positive immunochemical staining for cytomegalovirus. These findings confirmed a diagnosis of CMV colitis. The patient was treated with intravenous ganciclovir and subsequent oral valganciclovir. His symptoms completely resolved, and he remained asymptomatic at follow-up 1.5 years after presentation.
Colitis is the most common extraocular manifestation of CMV disease in HIV-infected patients, accounting for 7.3% of cases [1] . It usually occurs in patients with CD4 cell counts of less than 100/mL [2] , and presents with diarrhea, abdominal pain, fever, and weight loss [3] . On rare occasions, CMV colitis could develop as immune reconstitution inflammatory syndrome after initiation of ART [4, 5] . Because life-threatening complications such as large bowel perforation can occur [4] , prompt diagnosis is important. CMV colitis should be considered in diarrheal patients with HIV infection even after initiation of ART. 
